The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment

Life Sciences

Volumn 90, Issue 1-2, 2012, Pages 66-70

  Pasquinucci, Lorella ^a   Parenti, Carmela ^a   Turnaturi, Rita ^a   Aricò, Giuseppina ^a   Marrazzo, Agostino ^a   Prezzavento, Orazio ^a   Ronsisvalle, Simone ^a   Georgoussi, Zafiroula ^b   Fourla, Danai Dionysia ^b   Scoto, Giovanna M ^a   Ronsisvalle, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Antinociceptive tolerance; Bifunctional drugs; Tail flick test

Indexed keywords

ANTINOCICEPTIVE AGENT; BENZOMORPHAN; DELTA OPIATE RECEPTOR AGONIST; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LP1; MORPHINE; MU OPIATE RECEPTOR AGONIST; SULFUR 35; UNCLASSIFIED DRUG;

CELL MEMBRANE; CELL STRAIN HEK293; CHRONIC PAIN; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; TAIL FLICK TEST;

RATTUS;

EID: 84655160824     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.10.024     Document Type: Article

References (38)

1. V.A. Alvarez, S. Arttamangkul, V. Dang, A. Salem, J.L. Whistler, and M. Von Zastrow Mu-opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization J Neurosci 22 2002 5769 5776 (Pubitemid 35386500)
2. C.P. Bailey, and M. Connor Opioids: cellular mechanisms of tolerance and physical dependence Curr Opin Pharmacol 5 2005 60 68 (Pubitemid 40124536)
3. B. Bie, and Z.Z. Pan Trafficking of central opioid receptors and descending pain inhibition Mol Pain 3 2007 37 43
4. R.J. Bodnar Endogenous opiates and behavior: 2009 Peptides 31 2010 2325 2359
5. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
6. C.M. Cahill, S.V. Holdridge, and A. Morinville Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia Trends Pharmacol Sci 28 2007 23 31 (Pubitemid 46049831)
7. K.G. Commons, S.A. Aicher, L.M. Kow, and D.W. Pfaff Presynaptic and postsynaptic relations of mu-opioid receptors to gamma-aminobutyric acid-immunoreactive and medullary-projecting periaqueductal gray neurons J Comp Neurol 419 2000 532 542 (Pubitemid 30185990)
8. N. Dietis, R. Guerrini, G. Calò, S. Salvadori, D.J. Rowbotham, and D.G. Lambert Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile Br J Anaesth 103 2009 38 49
9. M. Eguchi Recent advances in selective opioid receptor agonists and antagonists Med Res Rev 24 2004 182 212 (Pubitemid 38230679)
10. P.J. Gengo, H.O. Pettit, S.J. O'Neill, K. Wei, R. McNutt, and M.J. Bishop DPI-3290 [(+)-3-((α-R)-α-((2S,5R)-4-allyl-2,5-dimethyl-1- piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity J Pharmacol Exp Ther 307 2003 1221 1226 (Pubitemid 37494245)
11. P.J. Gengo, H.O. Pettit, S.J. O'Neill, Y.F. Su, R. McNutt, and K.-J. Chang DPI-3290 [(+)-3-((α-R)-α-((2S,5R)-4-allyl-2,5-dimethyl-1- piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function J Pharmacol Exp Ther 307 2003 1227 1233 (Pubitemid 37494246)
12. Z. Georgoussi, and C. Zioudrou Effect of delta-opioid antagonists on the functional coupling between opioid receptors and G-proteins in rat brain membranes Biochem Pharmacol 45 1993 2405 2410 (Pubitemid 23189532)
13. Z. Georgoussi, M. Merkouris, I. Mullaney, G. Megaritis, C. Carr, and C. Zioudrou Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the C-terminal tail in coupling Biochim Biophys Acta 1359 1997 263 274 (Pubitemid 28027124)
14. S.L. Ingram, and J.R. Traynor Role of protein kinase C in functional selectivity for desensitization at the mu-opioid receptor: from pharmacological curiosity to therapeutic potential Br J Pharmacol 158 2009 154 156
15. B.L. Kieffer, and C. Gavériaux-Ruff Exploring the opioid system by gene knockout Prog Neurobiol 66 2002 285 306 (Pubitemid 34518287)
16. Y.S. Lee, V. Kulkarani, S.M. Cowell, S.-W. Ma, P. Davis, and K.E. Hanlon Development of potent μ and δ opioid agonists with high lipophilicity J Med Chem 54 2011 382 386
17. L.J. Leontiadis, M.P. Papakonstantinou, and Z. Georgoussi Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling Cell Signal 21 2009 1218 1228
18. H. McQuay Opioids in pain management Lancet 353 1999 2229 2232 (Pubitemid 29295264)
19. F. Meng, Q. Wei, M.T. Hoversten, L.P. Taylor, and H. Akil Switching agonist/antagonist properties of opiate alkaloids at the delta opioid receptor using mutations based on the structure of the orphanin FQ receptor J Biol Chem 275 2000 21939 21945 (Pubitemid 30621766)
20. R.W. Milne, R.L. Nation, and A.A. Somogyi The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine Drug Metab Rev 28 1996 345 472 (Pubitemid 26300413)
21. E. Morou, and Z. Georgoussi Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors J Pharmacol Exp Ther 315 2005 1368 1379 (Pubitemid 41635427)
22. R. Morphy, and Z. Rankovic Designed multiple ligands. An emerging drug discovery paradigm J Med Chem 48 2005 6523 6543 (Pubitemid 41504710)
23. S.S. Negus, A.E. Bear, J.E. Folk, and K.C. Rice Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys Eur J Pharmacol 602 2009 92 100 (Pubitemid 44373893)
24. A. Niedernberg, S. Tunaru, A. Blaukat, B. Harris, and E. Kostenis Comparative analysis of functional assays for characterization of agonist ligands at G protein-coupled receptors J Biomol Screen 8 2003 500 510
25. L. Pasquinucci, O. Prezzavento, A. Marrazzo, E. Amata, S. Ronsisvalle, and Z. Georgoussi Evaluation of N-substitution in 6,7-benzomorphan compounds Bioorg Med Chem 18 2010 4975 4982
26. O. Prezzavento, L. Pasquinucci, and E. Arena Opioid multiple ligands S. Rapposelli, Multifunctional drugs: new chimeras in medicinal chemistry 2010 Transworld Research Network India 99 127
27. G. Ronsisvalle, L. Pasquinucci, M.S. Pappalardo, F. Vittorio, G. Fronza, and C. Romagnoli Non-peptide ligands for opioid receptors. Design of kappa-specific agonists J Med Chem 36 1993 1860 1865 (Pubitemid 23203744)
28. G. Ronsisvalle, O. Prezzavento, L. Pasquinucci, A. Marrazzo, F. Vittorio, and J.A. Gomez-Vidal CCB, a novel specific kappa opioid agonist, which discriminates between opioid and sigma 1 recognition sites Life Sci 57 1995 1487 1495
29. P.W. Schiller Bi- or multifunctional opioid peptide drugs Life Sci 86 2010 598 603
30. G.M. Scoto, G. Aricò, A. Iemolo, G. Ronsisvalle, and C. Parenti Selective inhibition of the NOP receptor in the ventrolateral periaqueductal gray attenuates the development and the expression of tolerance to morphine-induced antinociception in rats Peptides 31 2010 696 700
31. G.W. Stevenson, J.E. Folk, D.C. Linsenmayer, K.C. Rice, and S.S. Negus Opioid interactions in rhesus monkeys: effects of δ + μ and δ + κ agonists on schedule-controlled responding and thermal nociception J Pharmacol Exp Ther 307 2003 1054 1064 (Pubitemid 37494225)
32. K.T. Sykes, S.R. White, R.W. Hurley, H. Mizoguchi, L.F. Tseng, and D.L. Hammond Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain J Pharmacol Exp Ther 322 2007 813 821 (Pubitemid 47105822)
33. H. Ueda, and M. Ueda Mechanisms underlying morphine analgesic tolerance and dependence Front Biosci 14 2009 5260 5272
34. R.M. van Rijn, and J.L. Whistler The only way is up: preventing opioid tolerance by promoting cell surface expression of MOR-DOR heterodimers? Mol Interv 8 2008 277 280
35. H.B. Wang, B. Zhao, Y.Q. Zhong, K.C. Li, Z.Y. Li, and Q. Wang Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons Proc Natl Acad Sci U S A 107 2010 13117 13122
36. T. Weiland, and K.H. Jakobs Measurement of receptor-stimulated guanosine 5′-O-(gamma-thio)triphosphate binding by G proteins Methods Enzymol 237 1994 3 13 (Pubitemid 24252174)
37. Z. Zhang, and Z.Z. Pan Synaptic mechanism for functional synergism between delta- and mu-opioid receptors J Neurosci 30 2010 4735 4744
38. X. Zhang, L. Bao, and J.S. Guan Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance Trends Pharmacol Sci 27 2006 324 329 (Pubitemid 44183608)